Compare GRFS & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | KEX |
|---|---|---|
| Founded | 1940 | 1921 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.0B |
| IPO Year | N/A | 1994 |
| Metric | GRFS | KEX |
|---|---|---|
| Price | $7.83 | $124.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $10.15 | ★ $127.75 |
| AVG Volume (30 Days) | ★ 682.6K | 594.5K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | N/A | ★ 28.92 |
| EPS | N/A | ★ 6.33 |
| Revenue | N/A | N/A |
| Revenue This Year | $5.33 | $4.19 |
| Revenue Next Year | $6.50 | $7.56 |
| P/E Ratio | ★ $18.67 | $19.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.19 | $79.52 |
| 52 Week High | $11.14 | $134.69 |
| Indicator | GRFS | KEX |
|---|---|---|
| Relative Strength Index (RSI) | 27.72 | 44.46 |
| Support Level | $7.64 | $109.37 |
| Resistance Level | $9.11 | $133.44 |
| Average True Range (ATR) | 0.29 | 4.35 |
| MACD | -0.12 | -1.01 |
| Stochastic Oscillator | 2.99 | 35.92 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's revenue is generated from the Marine Transportation segment.